drugset / Trial / NCT03278548

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

NCT03278548 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to investigate the safety of a 6% HES (Hydroxyethyl Starch) solution (Volulyte 6%) versus an electrolyte solution (Ionolyte) in patients undergoing elective abdominal surgery.

Timeline

Start
2017-09-28
Primary completion
2022-04-09
Completion
2022-07-06

Outcome

Met primary endpoint

paper Peri-operative use of HES was noninferior to crystalloids in short-term renal function or a composite of mortality and major complications at 90 days. PMID 41133731 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ionolyte Other / unclassified — —
Subject Volulyte 6% Other / unclassified 6 % —

Indications